More than €2bn is being spent by the State on medicines each year — it is taking an increasing share of the healthcare budget and we should be insisting on getting better value for money from the drug companies, the head of the National Centre for Pharmacoeconomics told doctors.
Sat, 07 Apr, 2018
John Hannan has been a ‘guinea pig’ for Respreeza for 11 years. Now, due to the reported €84k-a-year cost, he faces losing access to a drug that’s proven a lifesaver. He talks to
Sat, 07 Oct, 2017
A key feature of the new agreement between the Irish Pharmaceutical Healthcare Association, the HSE, and Department of Health, announced last week, is the promise of faster access to medicines once they have been proven to be cost-effective.
Mon, 31 Dec, 2012